• 제목/요약/키워드: Biomarker gene

검색결과 230건 처리시간 0.034초

MicroRNA-23a: A Novel Serum Based Diagnostic Biomarker for Lung Adenocarcinoma

  • Lee, Yu-Mi;Cho, Hyun-Jung;Lee, Soo-Young;Yun, Seong-Cheol;Kim, Ji-Hye;Lee, Shin-Yup;Kwon, Sun-Jung;Choi, Eu-Gene;Na, Moon-Jun;Kang, Jae-Ku;Son, Ji-Woong
    • Tuberculosis and Respiratory Diseases
    • /
    • 제71권1호
    • /
    • pp.8-14
    • /
    • 2011
  • Background: MicroRNAs (miRNAs) have demonstrated their potential as biomarkers for lung cancer diagnosis. In recent years, miRNAs have been found in body fluids such as serum, plasma, urine and saliva. Circulating miRNAs are highly stable and resistant to RNase activity along with, extreme pH and temperatures in serum and plasma. In this study, we investigated serum miRNA profiles that can be used as a diagnostic biomarker of non-small cell lung cancer (NSCLC). Methods: We compared the expression profile of miRNAs in the plasma of patients diagnosed with lung cancer using an miRNA microarray. The data from this assay were validated by quantitative real-time PCR (qRT-PCR). Results: Six miRNAs were overexpressed and three miRNAs were underexpressed in both tissue and serum from squamous cell carcinoma (SCC) patients. Sixteen miRNAs were overexpressed and twenty two miRNAs were underexpressed in both tissue and serum from adenocarcinoma (AC) patients. Of the four miRNAs chosen for qRT-PCR analysis, the expression of miR-23a was consistent with microarray results from AC patients. Receiver operating characteristic (ROC) curve analyses were done and revealed that the level of serum miR-23a was a potential marker for discriminating AC patients from chronic obstructive pulmonary disease (COPD) patients. Conclusion: Although a small number of patients were examined, the results from our study suggest that serum miR-23a can be used in the diagnosis of AC.

Immuno-chromatographic Analysis for HPV-16 and 18 E7 Proteins as a Biomarker of Cervical Cancer Caused by Human Papillomavirus

  • Kim, Joo-Ho;Cho, Il-Hoon;Seo, Sung-Min;Kim, Ji-Sook;Oh, Kyu-Ha;Kang, Heun-Soo;Kim, In-Gyu;Paek, Se-Hwan
    • Bulletin of the Korean Chemical Society
    • /
    • 제30권12호
    • /
    • pp.2999-3005
    • /
    • 2009
  • Among the more than 120 different types of human papillomavirus (HPV), types 16 and 18 have been known to be high risk agents that cause cervical cancer. We examined, in an immuno-chromatographic analysis, the potential of using the early gene product, E7 protein, as a diagnostic marker of cervical cancer caused by HPV. We developed monoclonal antibodies specific to HPV-16 and 18 E7 proteins that were produced from bacterial cells using gene recombinant technology. For each E7 protein, the optimal antibody pair was selected using the immuno-chromatographic sandwichtype binding system based on the lateral flow through membrane pores. Under these conditions, this rapid testing assay had a detection capability as low as 2 ng/mL of E7 protein. Furthermore, since viral analysis required the host cell to be lysed using chemicals such as detergents, it was possible that the E7 protein was structurally damaged during this process, which would result in a decrease in detection sensitivity. Therefore, we examined the detrimental effects caused by different detergents on the E7 protein using HeLa cells as the host. In these experiments, we found that the damage caused by the detergent, nonylphenylpolyethylene glycol (NP-40), was minimal relative to Triton X-100 commonly used for the cell lysis. Temperature also affected the stability of the E7 protein, and we found that the E7 protein was stabilized at 4$^{\circ}C$ for about 2 h, which was 4 times longer than at room temperature. Finally, a HPV-infected cervical cancer cell line, which was used as a real sample model, was treated using the optimized conditions and the presence of E7 proteins were analyzed by immuno-chromatography. The results of this experiment demonstrated that this rapid test could specifically detect HPV-infected samples.

Quantification of Serum Free RNA as a Predictive Biomarker for the Response to Chemotherapy in Patients with Lung Cancer: A Pilot Study

  • Um, Soo-Jung;Lee, Su-Mi;Lee, Soo-Keol;Son, Choon-Hee;Ko, Mee-Kyung;Roh, Mee-Sook;Lee, Ki-Nam;Choi, Pil-Jo
    • Tuberculosis and Respiratory Diseases
    • /
    • 제70권4호
    • /
    • pp.301-306
    • /
    • 2011
  • Background: It is well-known that cell-free nucleic acids rise in patients with many types of malignancies. Several recent experimental studies using cancer cell lines have shown that changes in cell-free RNA are predictive of the response to chemotherapy. The objective of this study was to determine whether quantification of free RNA can be used as a biomarker for clinical responses to chemotherapy in patients with lung cancer. Methods: Thirty-two patients with lung cancer (non-small cell lung cancer, n=24; small cell lung cancer, n=8) were divided into 2 groups according to their responses to chemotherapy (response group, n=19; non-response group, n=13). Blood samples were collected before and after two cycles of chemotherapy. Real-time quantitative RT-PCR was used for transcript quantification of the glyceraldehyde-3-phosphate dehydrogenase gene. Results: The pre chemotherapy values (Response group $41.36{\pm}1.72$ vs. Non-response group $41.33{\pm}1.54$, p=0.78) and post chemotherapy values (Response group $39.92{\pm}1.81$ vs. Non-response group $40.41{\pm}1.47$, p=0.40) for cell free RNA concentrations, expressed as Ct GAPDH (threshold cycle glyceraldehyde-3-phosphate dehydrogenase gene) levels, was not different between the two groups. There was no significant relationship between changes in the cell free RNA level clinical responses after chemotherapy (p=0.43). Conclusion: We did not find a correlation between quantification of serum cell free RNA levels and clinical responses to chemotherapy in patients with lung cancer. Further investigations are needed to determine whether the cell free RNA level is a useful predictor of responses to chemotherapy in patients with lung cancer.

사람 핵DNA로부터 FosB 유전자 프로모터 클로닝 및 활성도 분석 (Cloning and Activity Analysis of the FosB Promoter Region from Human Genomic DNA)

  • 나한흠;강윤성;김근철
    • 생명과학회지
    • /
    • 제27권8호
    • /
    • pp.857-863
    • /
    • 2017
  • FosB (FBJ murine osteosarcoma viral oncogene homolog B) 유전자는 사람의 19번 염색체에 위치하고 있으며 약 43 KD의 단백질을 코딩하며, 발생 및 분화과정, 개체 유지, 발병 진행 등을 조절한다고 알려져 왔다. 본 연구에서는 바이오 마커 등의 가능성이 있다고 보고된 FosB 유전자의 프로모터를 클로닝하여 활성도를 분석하고자 하였다. FosB genomic DNA 서열을 확인한 결과, TSS upstream 방향의 약 1 Kb 안쪽 부위에 FosB 유전자 발현을 위한 중요한 요소들이 있을 것으로 추정하였고, 따라서 FosB genomic DNA의 upstream -1,555 부위부터 exon 1의 +73까지 부위에 대한 PCR 증폭을 수행하였다. 또한 클로닝 성공을 높이기 위하여 일차로 $TA-1^{st}FosBp$ plasmid를 얻은 후, 다시 $TA-1^{st}FosBp$ plasmid를 template로 Kpn1과 Nhe1 제한 효소 절단부위를 프라이머에 삽입한 후 제작하여 2차 PCR을 수행하였으며, $TA-2^{nd}FosBp$ 플라스미드를 제작한 후 제한 효소로 절단하여 pGL3-luc vector로 subcloning하였다. 제작된 pGL3-FosBp-luc를 이용하여 항암제에 대한 활성도를 분석하고자 A549 사람 폐암세포주에 pGL3-FosBp-luc 플라스미드를 transfection 한 후 luciferase 활성도 분석을 수행하였다. Luciferase 활성도 증가는 doxorubicin, taxol 등을 처리한 후 단백질 발현 양상과 비교 하였을 때도 일치되는 결과를 얻을 수 있었다. 그러므로 FosB프로모터 클로닝은 향후 유전자 발현 연구, 마커분석 등에 유용할 것으로 사료된다.

당 생합성 효소 PGK 유전자 프로모터 변이와 물렁증 저항성 멍게의 선별 (Gene Promoter Variation of Phosphoglycerate Kinase, a Glucose Metabolism Enzyme, is a Biomarker for Selection of Disease-resistant Sea Squirt, Halocynthia Roretzi)

  • 조현국;허영백;정재훈
    • 생명과학회지
    • /
    • 제23권2호
    • /
    • pp.190-196
    • /
    • 2013
  • 멍게의 물렁증 발병으로 인해 멍게 양식에 커다란 타격을 받고 있는 가운데 물렁증 발병에 대한 분자적인 접근을 위해 정상 멍게와 물렁증 걸린 멍게에서 DEG 법을 수행하였다. 이번 연구에서 멍게의 당 생합성 효소인 PGK가 물렁증에 걸린 멍게 개체에서 발현이 감소하는 것을 다양한 실험을 통해서 확인하였다. PGK에 대한 유전자 서열을 확보함과 동시에 이 유전자의 발현에 영향을 미치는 부위인 프로모터를 클로닝 하였다. 프로모터 부위의 단일 염기 다형성 분석을 통해서 -106과 -254 위치의 염기에서 다형성이 일어나는 것을 확인하였다. 물렁증에 대한 저항성을 가진 멍게와 다른 개체군의 멍게와의 염기서열을 비교한 결과 많은 차이가 나타남을 확인하였다. 이러한 염기의 차이가 PGK의 발현에 영향을 미치는 지 확인하기 위해서 각각의 멍게 개체군에서 genomic DNA와 total RNA를 분리하여 genotyping과 RT-PCR을 수행하였다. 그 결과 -106과 -254 위치의 염기가 AA와 GT인 개체에서 PGK의 발현량이 상대적으로 많은 것을 확인할 수 있었다. 이러한 결과는 물렁증에 대한 저항성을 가진 멍게를 선발육종하기 위한 분자적인 마커의 개발에 활용됨으로써 물렁증 발병을 줄일 수 있음을 시사하였다.

Role of P14 and MGMT Gene Methylation in Hepatocellular Carcinomas: a Meta-analysis

  • Li, Cheng-Cheng;Yu, Zhuang;Cui, Lian-Hua;Piao, Jin-Mei;Liu, Meng
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권16호
    • /
    • pp.6591-6596
    • /
    • 2014
  • Background: This meta-analysis was performed to investigate the relationship between methylation of the P14 and O6-methylguanine-DNA methyltransferase (MGMT) genes and the risk of hepatocellular carcinoma (HCC). Materials and Methods: We searched PubMed, EMBASE, the Chinese Biomedical Database (CBM), and the China National Knowledge Infrastructure (CNKI) databases to identify relevant studies that analysed HCC tissues for P14 and MGMT gene methylation status; we then performed a meta-analysis. Odds ratios (ORs) and 95% confidence intervals (95%CIs) were calculated to evaluate the association between gene methylation and the risk of HCC. Results: Ten studies that assessed P14 gene methylation in 630 HCC tumour tissues and nine studies analysing MGMT methylation in 497 HCC tumour tissues met our inclusion criteria. Our meta-analysis revealed that the rate of P14 methylation was significantly higher in HCCs than in adjacent tissues (OR 3.69, 95%CI 1.63-8.35, p=0.002), but there was no significant difference in MGMT methylation between HCC and adjacent tissues (OR 1.76, 95%CI 0.55-5.64, p=0.34). A subgroup analysis according to ethnicity revealed that P14 methylation was closely related to the risk of HCC in Chinese and Western individuals (Chinese, OR 7.74, 95%CI 1.36-44.04, p=0.021; Western, OR 3.60, 95%CI 1.49-8.69, p=0.004). Furthermore, MGMT methylation was not correlated with the risk of HCC in Chinese individuals (OR 2.42, 95%CI 0.76-7.73, p=0.134). The combined rate of P14 methylation was 35% (95%CI 24-48%) in HCC tumour tissues and 11% (95%CI 4-27%) in adjacent tissues, whereas the combined rate of MGMT methylation was 15% (95%CI 6-32%) in HCC and 10% (95%CI 4-22%) in adjacent tissues. Conclusions: These results suggest that the risk of HCC is related to P14 methylation, but not MGMT methylation. Therefore, P14 gene methylation may be a potential biomarker for the diagnosis of HCC.

New Gene Profiling in Determination of Breast Cancer Recurrence and Prognosis in Iranian Women

  • Poorhosseini, Seyed Mohammad;Hashemi, Mohammad;Olyaei, Nasrin Alipour;Izadi, Amir;Moslemi, Elham;Ravesh, Zeinab;Hashemi-Gorji, Feyzollah;Kheiri, Hamid Reza;Yassaee, Vahid Reza
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제17권sup3호
    • /
    • pp.155-160
    • /
    • 2016
  • Breast cancer (BC) is the second most common cancer in the world and by far the most frequent cancer among women, with an estimated 1.67 million new cancer cases diagnosed in 2012 (25% of all cancers). Polygene expression analysis is used to predict the prognosis and determine the most appropriate treatment regimen. The objective of this study was to examine the gene expression profiles of SIRT3, HRAS, LSP1, SCUBE2 and AP2A2 in Iranian women with BC.A total of 136 patients including healthy controls were categorized into three groups based on the relapse of the disease. Expression of desired genes in formalin-fixed, paraffin embedded tissues collected from all groups of participants was analyzed via the RT PCR method. RNA extraction and cDNA synthesis were performed then real-time quantitative PCR was carried out. Gene expression analysis revealed that the expression of SIRT3 was equal among patient and control groups. LSP1 was down regulated in all patient groups relative to controls but reduced expression in the metastatic group relative to the non-metastatic one was not significant. HRAS was significantly overexpressed in total and metastatic tumor samples versus normal but not in non-metastatic cases. SCUBE2 expression showed significant over-expression in both overall tumor samples and the non-metastatic group as compared to normal tissues. Gene expression level of AP2A2 in all groups was not detectable. Our data are compatible with a tumor suppressor role of LSP1 related to potential prognostic factor for tumor recurrence and outcome. This study for the first time assayed the prognostic value and changes in the expression of SIRT3, LSP1, HRAS, SCUBE2 and AP2A2 genes in women with breast cancer in the Iranian population and findings confirmed potential biomarker and prognostic capability of these genes. Such expression profiling data can critically improve prognosis and treatment decisions in cancer patients.

수환경 내 Estrogen 에스트로젠 활성 검출을 위한 누치 난황전구단백질 유전자 발현의 RT-PCR시험법 (Analysis of Vitellogenin Gene Expression by RT-PCR in Hemibarbus labeo (Cyprinidae) for the Analysis of Estrogenic Activity in Aquatic Environment)

  • 계명찬
    • 생태와환경
    • /
    • 제37권1호통권106호
    • /
    • pp.122-129
    • /
    • 2004
  • In an effort to develop the biomarker for monitoring the contamination of xenoestrogen in the freshwater environment of Korea, reverse transcription-polymerasechain reaction (RT-PCR) analysis of vitellogenin (VTG) gene expression was optimized in Hearisarsus Iaseo, Based on the homology of the VTG cDNA sequences between the common carp and zebra fish, a set of PCR primers for VTG mRNA amplification for H; labo was designed. VTG mRNA level in livers from female and male fishes was analyzed by RT-PCR following single injection of 17 beta estradiol($E_2$ 10 mg $kg^{-1}$ B.W.). As an internal control, beta actin mRNA was amplified. One us of total liver RNA was subjected to RT-PCR. In female the amount of PCR productof VfC gradually increased in the range from 16 to 34 cycles of amplification. On the contrary, in control male, PCR product first detected at 32 cycles of amplification and linearly increased up to 40 cycles of amplification. In $E_2$ injected male liver, the VTC mRNA level was similar to that in the female. Taken together, this result suggests that liver of male H. labo expresses minute amount of VTG mRNA which are2-l6 equivalent of female and that induction of VTG mRNA occurs in male liver after estrogen treatment. In conclusion, the optimized protocol for RT-PCR analysis of VTG mRNA expression in liver of male H. labo will provide the environmental monitoring method for the xenoestrogen contamination in the rivers in Korea.

수온 및 염분 스트레스에 따 른 참담치, Mytilus coruscus에서 Hsp70 및 GST 유전자 발현에 대한 연구 (The Expression of Hsp70 and GST Genes in Mytilus coruscus Exposed to Water Temperature and Salinity)

  • 김철원;강한승
    • 환경생물
    • /
    • 제33권4호
    • /
    • pp.450-458
    • /
    • 2015
  • The heat shock proteins (Hsps), one of the most highly conserved groups of proteins, play crucial roles in protecting cells against environmental stressors, such as temperature, salinity, heavy metals and pathogenic bacteria. The glutathione S-transferases (GST) have important role in detoxification of oxidative damage, environmental chemicals and environmental stress. The purpose of this study is to investigate the gene expression of Hsp70 and GST on change of temperature and salinity in Mytilus coruscus. The M. coruscus was cultured in incubator of separate temperature and salinity (8, 20, $30^{\circ}C{\times}20$‰, 25‰, 30‰) for 28 days. Ten individuals in each group were selected after each 14 and 28 days exposure. Results that the expression of Hsp70 mRNA was no significant changed in M. coruscus exposed to temperature ($8^{\circ}C$, $20^{\circ}C$, $30^{\circ}C$) and salinity (20‰, 25‰, 30‰) for 14 days. Whereas the expression of Hsp70 mRNA was increased in exposure to temperature $30^{\circ}C$ and salinity (20‰, 25‰, 30‰) for 28 days. The expression of GST mRNA was increased in exposure to temperature $30^{\circ}C$, salinity (25‰, 30‰) for 14 days and temperature ($8^{\circ}C$, $20^{\circ}C$, $30^{\circ}C$), salinity (20‰, 25‰, 30‰) for 28 days. These results suggest that Hsp70 and GST were played roles in biomarker gene on the thermal and salinity stress.

Long non-coding RNA: its evolutionary relics and biological implications in mammals: a review

  • Dhanoa, Jasdeep Kaur;Sethi, Ram Saran;Verma, Ramneek;Arora, Jaspreet Singh;Mukhopadhyay, Chandra Sekhar
    • Journal of Animal Science and Technology
    • /
    • 제60권10호
    • /
    • pp.25.1-25.10
    • /
    • 2018
  • The central dogma of gene expression propounds that DNA is transcribed to mRNA and finally gets translated into protein. Only 2-3% of the genomic DNA is transcribed to protein-coding mRNA. Interestingly, only a further minuscule part of genomic DNA encodes for long non-coding RNAs (lncRNAs) which are characteristically more than 200 nucleotides long and can be transcribed from both protein-coding (e.g. H19 and TUG1) as well as non-coding DNA by RNA polymerase II. The lncRNAs do not have open reading frames (with some exceptions), 3`-untranslated regions (3'-UTRs) and necessarily these RNAs lack any translation-termination regions, however, these can be spliced, capped and polyadenylated as mRNA molecules. The flexibility of lncRNAs confers them specific 3D-conformations that eventually enable the lncRNAs to interact with proteins, DNA or other RNA molecules via base pairing or by forming networks. The lncRNAs play a major role in gene regulation, cell differentiation, cancer cell invasion and metastasis and chromatin remodeling. Deregulation of lncRNA is also responsible for numerous diseases in mammals. Various studies have revealed their significance as biomarkers for prognosis and diagnosis of cancer. The aim of this review is to overview the salient features, evolution, biogenesis and biological importance of these molecules in the mammalian system.